John B. Craig - Concepedia

Author

John B. Craig

The University of Texas Health Science Center at San Antonio

Also Known As

J B Craig, J. B. Craig, J.B. Craig, JOHN B. CRAIG, John B Craig, John B. Craig, M L Rothenberg

Publications

753

Citations

H-Index

Concepts

All Affiliations

The University of Texas Health Science Center at San Antonio Wayne State University

About

John B. Craig is an author at The University of Texas Health Science Center at San Antonio specializing in medicine, oncology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	272
2	Health Sciences	3	3	244
3	Pathology	3	3	182
4	Immunology	1	1	129
5	Neurology	1	1	72

John B. Craig

Publications

450

Citations

H-Index

Page 1

	Year	Citations
Tumor Necrosis Factor Not Detectable in Patients With Clinical Cancer Cachexia Susan H. Socher, D. Martínez, John B. Craig, JNCI Journal of the National Cancer Institute Metabolic DisorderClinical Cancer CachexiaHuman TnfImmunologyPathology	1988	129
Prospective evaluation of changes in computed cranial tomography in patients with small cell lung carcinoma treated with chemotherapy and prophylactic cranial irradiation. John B. Craig, Don V. Jackson, D. M. Moody, Journal of Clinical Oncology Cerebral AtrophyOncologic ImagingComputed Cranial TomographyBrain LesionNeuro-oncology	1984	72
Evaluation of Amonafide in Cervical Cancer, Phase II Vinay K. Malviya, P. Y. Liu, David S. Alberts, American Journal of Clinical Oncology	1992	59
Multicenter phase II study of weekly oral vinorelbine for stage IV non-small-cell lung cancer. Everett E. Vokes, Richard K. Rosenberg, Mohammad Jahanzeb, Journal of Clinical Oncology	1995	43
Phase I clinical investigation of amonafide. Ruben A. Saez, John B. Craig, John G. Kuhn, Journal of Clinical Oncology Hematological MalignancyAmonafide PlasmaOncologyDrug InfusionMedicine	1989	43
Phase I Clinical and Pharmacokinetic Trial of Flavone Acetic Acid A. K. Havlin, John G. Kuhn, John B. Craig, JNCI Journal of the National Cancer Institute	1991	24
Phase I and clinical pharmacology trial of crisnatol (BWA770U mesylate) using a monthly single-dose schedule. G. S. Harman, John B. Craig, John G. Kuhn, PubMed Crisnatol Plasma ConcentrationsPharmacotherapyPre-clinical PharmacologyNeuro-oncologyMedicinal Chemistry	1988	18
Phase II Trial of Amonafide for the Treatment of Advanced, Hormonally Refractory Carcinoma of the Prostate M. Ernest Marshall, Brent A. Blumenstein, E. David Crawford, American Journal of Clinical Oncology	1994	17
The relationship between the emotional intelligence of the principal and teacher job satisfaction John B. Craig ScholarlyCommons (University of Pennsylvania)	2008	13
Phase II Trial of Amonafide in Patients with Advanced Metastatic or Recurrent Endometrial Adenocarcinoma A Southwest Oncology Group Study Vinay K. Malviya, P. Y. Liu, David S. Alberts, American Journal of Clinical Oncology	1994	12

Page 1